Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Convertible Debt (2024 - 2025)

Lemaitre Vascular (LMAT) has disclosed Convertible Debt for 2 consecutive years, with $168.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Convertible Debt rose 0.52% to $168.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $168.6 million, a 0.52% increase, with the full-year FY2025 number at $168.6 million, up 0.52% from a year prior.
  • Convertible Debt was $168.6 million for Q4 2025 at Lemaitre Vascular, roughly flat from $168.4 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $168.6 million in Q4 2025 to a low of $167.8 million in Q4 2024.